Compile Data Set for Download or QSAR
Report error Found 384 Enz. Inhib. hit(s) with all data for entry = 13037
TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753891(US20250206717, Example 306)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753635(US20250206717, Example 42)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753890(US20250206717, Example 305)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753634(US20250206717, Example 41)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753889(US20250206717, Example 304)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753633(US20250206717, Example 40)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753632(Preparation of 6-((1-acetylazacyclobutane-3-yl)ami...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753887(US20250206717, Example 302)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753631(Preparation of 6-((1-acetylpiperidine-4-yl)amino)-...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753629(Preparation of trans-(4-(3,4-dihydroisoquinoline-2...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753900(US20250206717, Example 316)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753899(US20250206717, Example 315)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753643(US20250206717, Example 50)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753898(US20250206717, Example 314)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753642(US20250206717, Example 49)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753897(US20250206717, Example 313)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753641(US20250206717, Example 48)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753896(US20250206717, Example 311)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753895(US20250206717, Example 310)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753894(US20250206717, Example 309)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753893(US20250206717, Example 308)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753637(US20250206717, Example 44)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753876(US20250206717, Example 290)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753619(Preparation of 2-(pentan-3-yloxy)-6-((1-(thiazole-...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753874(US20250206717, Example 288)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753873(US20250206717, Example 287)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753616(Preparation of 6-((1-(tert-butoxycarbonyl)piperidi...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753871(US20250206717, Example 285)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753615(Preparation of 2-isopropoxy-6-((1-(pyrimidine-4-yl...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753870(US20250206717, Example 284)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753614(Preparation of 6-((2-acetyl-2-azaspiro[3.3]heptan-...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753869(US20250206717, Example 283)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753613(US20250206717, Example 19)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753884(Preparation of trans-1-(4-((6-(4-(3,4-dihydroisoqu...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753628(Preparation of 6-((1-acetylpiperidine-4-yl)amino)-...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753883(Preparation of 1-(4-((6-(trans-4-(3,4-dihydroisoqu...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753627(Preparation of 6-((1-acetylpiperidine-4-yl)amino)-...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753882(Preparation of 1-(4-((6-(trans-4-(3,4-dihydroisoqu...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753881(Preparation of 1-(4-((6-((3R,4R)-4-(3,4-dihydroiso...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753880(US20250206717, Example 294)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753879(US20250206717, Example 293)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753878(US20250206717, Example 292)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753622(Preparation of 6-((1-(cyclobutanecarbonyl)piperidi...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753621(Preparation of ((3R,4R)-4-(3,4-dihydroisoquinoline...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753924(US20250206717, Example 342)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753923(US20250206717, Example 341)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753921(US20250206717, Example 339)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM700386(US20240336593, Example 149 | US20250206717, Exampl...)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753663(US20250206717, Example 72)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Innovstone Therapeutics

US Patent
LigandPNGBDBM753932(US20250206717, Example 351)
Affinity DataIC50: 20nMAssay Description:A 1× enzyme reaction buffer (10 mM Tris 8.0 (Sigma, Cat. No. T2694-1L), 0.01% Tween-20 (Sigma, Cat. No. P2287-100ML), and 1 mM DTT (Sigma, Cat. No. D...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/20/2025
Entry Details
US Patent

Displayed 1 to 50 (of 384 total ) | Next | Last >>
Jump to: